| Acinetobacter baumannii Infection-Related Mortality in Hospitalized Patients: Risk Factors and Potential Targets for Clinical and Antimicrobial Stewardship … D Alrahmany, AF Omar, A Alreesi, G Harb, IM Ghazi Antibiotics 11 (8), 1086, 2022 | 32 | 2022 |
| Exploring bacterial resistance in Northern Oman, a foundation for implementing evidence-based antimicrobial stewardship program D Al Rahmany, A Albeloushi, I Alreesi, A Alzaabi, M Alreesi, L Pontiggia, ... International Journal of Infectious Diseases 83, 77-82, 2019 | 17 | 2019 |
| Risk factors for recurrence of Clostridioides difficile in hospitalized patients D Alrahmany, BJ Ereshefsky, WS El Nekidy, G Harb, L Pontiggia, ... Journal of Infection and Public Health 14 (11), 1642-1649, 2021 | 15 | 2021 |
| Acinetobacter baumannii Infections in Hospitalized Patients, Treatment Outcomes D Alrahmany, AF Omar, G Harb, WS El Nekidy, IM Ghazi Antibiotics 10 (6), 630, 2021 | 13 | 2021 |
| Acinetobacter baumannii Infection-Related Mortality in Hospitalized Patients: Risk Factors and Potential Targets for Clinical and Antimicrobial Stewardship Interventions … D Alrahmany, AF Omar, A Alreesi, G Harb, IM Ghazi s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | 7 | 2022 |
| Infections in G6PD-Deficient Hospitalized Patients—Prevalence, Risk Factors, and Related Mortality D Alrahmany, AF Omar, SRS Al-Maqbali, G Harb, IM Ghazi Antibiotics 11 (7), 934, 2022 | 4 | 2022 |
| Cytokine storm is the cryptic killer behind coronavirus disease-2019 infections, review of the current evidence to identify therapeutic options D Alrahmany, IM Ghazi Reviews and Research in Medical Microbiology 32 (1), 57-65, 2021 | 4 | 2021 |
| Optimal vancomycin dose in the treatment of Clostridium difficile infection, antimicrobial stewardship initiative BJ Ereshefsky, D Alrahmany, WS El Nekidy, L Pontiggia, IM Ghazi Journal of Chemotherapy 33 (3), 165-173, 2021 | 2 | 2021 |
| Risk factors associated with the mortality of Acinetobacter baumannii D Alrahmany, S Golchinheydari, I M. Ghazi Access Microbiology 2 (7A), 441, 2020 | 2 | 2020 |
| Infections in Glucose-6-Phosphate Dehydrogenase G6PD-Deficient Patients; Predictors for Infection-Related Mortalities and Treatment Outcomes D Alrahmany, AF Omar, W Hafez, S Albaloshi, G Harb, IM Ghazi Antibiotics 12 (3), 494, 2023 | 1 | 2023 |
| Multi-drug resistant Acinetobacter baumannii infection, risk factors for mortality D Alrahmany, L Pontiggia, I Ghazi International Journal of Infectious Diseases 101, 158, 2020 | 1 | 2020 |
| Clinical Outcomes of Trimethoprim/Sulfamethoxazole in Critically Ill Patients with Stenotrophomonas maltophilia Bacteremia and Pneumonia Utilizing Renal … WS El Nekidy, K Al Zaman, E Abidi, D Alrahmany, IM Ghazi, R El Lababidi, ... Journal of Clinical Medicine 13 (8), 2275, 2024 | | 2024 |
| 1733. Stability of Imipenem/Cilastatin/Relebactam under Different Temperature and Administration Conditions I Ghazi, D Alramany, G Harb, D Nicolau Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 1363, 2022 | | 2022 |
| Infections in G6PD-Deficient Hospitalized Patients—Prevalence, Risk Factors, and Related Mortality. Antibiotics 2022, 11, 934 D Alrahmany, AF Omar, SRS Al-Maqbali, G Harb, IM Ghazi s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
| Acinetobacter baumannii Infections in Hospitalized Patients, Treatment Outcomes. Antibiotics 2021, 10, 630 D Alrahmany, AF Omar, G Harb, WS El Nekidy, IM Ghazi s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | | 2021 |
| Clostridium difficile infection risk of recurrence and candidates for preventive therapy, a stewardship approach I Ghazi, L Pontiggia, D Alrahmany, W El Nekidy International Journal of Infectious Diseases 101, 369, 2020 | | 2020 |
| Evolving Rapid Diagnostics Tools D Alrahmany, IM Ghazi 21st Century Challenges in Antimicrobial Therapy and Stewardship 3, 172, 2020 | | 2020 |
| Molecular Basis of Resistance II D Alrahmany, IM Ghazi 21st Century Challenges in Antimicrobial Therapy and Stewardship 3, 104, 2020 | | 2020 |
| Molecular Basis of Resistance III IM Ghazi, D Alrahmany, WS El Nekidy 21st Century Challenges in Antimicrobial Therapy and Stewardship 3, 149, 2020 | | 2020 |
| Cluster cases of Middle East Respiratory Syndrome Corona virus (MERS-CoV) in Oman I Ghazi, D Al Rahmany 19th International Congress on Infectious Diseases, 2020 | | 2020 |
Islam M. GhaziLong Island UniversityVerified email at liu.edu
